Company lists · Data refreshed September 2026

Top 15 Brain disease biotech startups based in the United Kingdom

RevenueBase identified 30 brain disease biotech startups headquartered in the United Kingdom as of September 2026 and tracks 716 professional contacts across them, including 197 with verified work emails. London is the largest hub.

This list covers brain disease biotech startups headquartered in the United Kingdom, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 16, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 16, 2026 86% judged on-target in blind review
30Companies
716Contacts tracked
197Verified emails
Explore this list → Free signup · no credit card · 500 free credits

The 15 largest brain disease biotech startups based in the United Kingdom

Ranked by team size
Top 15 of 30 brain disease biotech startups based in the United Kingdom, ranked by team size, largest first. Data refreshed Sep 16, 2026. RevenueBase Smart Search rates how each company's information relates to brain disease biotech startups: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#CompanyRevenueBase Smart SearchHeadquartersEmployeesContacts
1Partial evidenceStevenage, United KingdomHQ checked Sep 16, 202611-5098 contacts →

Partial evidence

“Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions.”

Source: RevenueBase Database · checked Sep 16, 2026
2Indirect evidenceLondon, United KingdomHQ checked Sep 16, 202611-5063 contacts →

Indirect evidence

“At AviadoBio, we are relentlessly chasing cures by translating groundbreaking science and precision delivery into life-changing medicines for people living with frontotemporal…”

Source: RevenueBase Database · checked Sep 16, 2026
3Partial evidenceCambridge, United KingdomHQ checked Sep 16, 202611-5028 contacts →

Partial evidence

“Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases

Source: RevenueBase Database · checked Sep 16, 2026
4Indirect evidenceOxford, United KingdomHQ checked Sep 16, 202611-5025 contacts →

Indirect evidence

“Neuro-Bio has discovered a novel 14 amino acid bioactive peptide (T14) derived from the C terminus of AChE.”

Source: RevenueBase Database · checked Sep 16, 2026
5Indirect evidenceLondon, United KingdomHQ checked Sep 16, 20261-1023 contacts →

Indirect evidence

“Built for precision, designed for patients.”

Source: RevenueBase Database · checked Sep 16, 2026
6Indirect evidenceLondon, United KingdomHQ checked Sep 16, 202611-5022 contacts →

Indirect evidence

“CoSyne Therapeutics is a vertically integrated AI Drug Discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served…”

Source: RevenueBase Database · checked Sep 16, 2026
7Partial evidenceLondon, United KingdomHQ checked Sep 16, 202611-509 contacts →

Partial evidence

“NWPharmaTech is a Clinical Stage Biotech Company with a focus on Psychiatric & Neurological Disorders.”

Source: RevenueBase Database · checked Sep 16, 2026
8Partial evidenceMacclesfield, United KingdomHQ checked Sep 16, 20261-107 contacts →

Partial evidence

“Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021.”

Source: RevenueBase Database · checked Sep 16, 2026
9Partial evidenceLondon, United KingdomHQ checked Sep 16, 20261-105 contacts →

Partial evidence

“Diadem’s goal is to be the first truly blood-based Prognostic (Px) test for early detection of dementia in Neurodegenerative disease with a particular focus to Alzheimer’s Disease.”

Source: RevenueBase Database · checked Sep 16, 2026
10Partial evidenceCambridge, United KingdomHQ checked Sep 16, 20261-105 contacts →

Partial evidence

“EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).”

Source: RevenueBase Database · checked Sep 16, 2026
11Partial evidenceLondon, United KingdomHQ checked Sep 16, 20261-104 contacts →

Partial evidence

“Bloomsbury Genetic Therapies ("Bloomsbury") is a clinical-stage biotechnology company, developing potentially curative treatments for patients suffering from rare neurological and…”

Source: RevenueBase Database · checked Sep 16, 2026
12Partial evidenceNether Alderley, United KingdomHQ checked Sep 16, 20261-104 contacts →

Partial evidence

“TheraCryf plc is a clinical stage therapeutics company developing a new generation of innovative therapeutics in oncology and behavioural brain disorders.”

Source: RevenueBase Database · checked Sep 16, 2026
13Strong evidenceCambridge, United KingdomHQ checked Sep 16, 20261-103 contacts →

Strong evidence

“Aila Biotech harnesses a patented gene delivery technology to drive the production of immune-regulating biologics at the site of disease.”

Source: RevenueBase Database · checked Sep 16, 2026
14Strong evidenceLondon, United KingdomHQ checked Sep 16, 20261-102 contacts →

Strong evidence

Brain diseases have no cures and affect 1 in 10 people worldwide and their families.”

Source: RevenueBase Database · checked Sep 16, 2026
15Partial evidenceMaidenhead, United KingdomHQ checked Sep 16, 20261-101 contacts →

Partial evidence

“Elixa MediScience is developing novel medicines capable of both delaying the onset and slowing the progression of neurodegenerative diseases

Source: RevenueBase Database · checked Sep 16, 2026

Showing 15 of 30 brain disease biotech startups based in the United Kingdom

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 197 reachable decision-makers.

Free signup · no credit card

View the full list →

Brain disease biotech startups based in the United Kingdom at a glance

As of Sep 16, 2026
27.5%Verified-email coverage
23.9Average contacts per company
1-10Median size (employees)
33.3%Largest-city concentration · London
Sep 16, 2026Page data refreshed

Companies by employee count

1-10
18
11-50
12

Email recency for this list is measured worldwide rather than for United Kingdom, so it is reported there. Company counts and contact totals on this page are exact for United Kingdom, over 30 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among brain disease biotech startups, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in the United Kingdom whose own description of what they do matches “brain disease biotech startups”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search
RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names brain disease biotech startups), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude
Companies whose own description does not clearly place them among brain disease biotech startups, and records with no verified work email. Companies headquartered outside United Kingdom are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 197 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 16, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names brain disease biotech startups, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many brain disease biotech startups are there based in the United Kingdom?

RevenueBase identified 30 brain disease biotech startups headquartered in the United Kingdom as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Spur Therapeutics, headquartered in Stevenage, tops this list with the largest team on record.

Which city has the most brain disease biotech startups?

London leads with 10 headquartered companies, followed by Cambridge (5) and Oxford (4).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 197 verified decision-maker contacts tracked across these 30 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 16, 2026.

Ready to reach these companies? Verified emails and direct dials for all 30 brain disease biotech startups based in the United Kingdom. Start with a free account, no credit card.

Download this list →

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.